Nakajo-Nishimura Syndrome: The First African Case

被引:0
|
作者
Ghodbane, Nacif Eddine [1 ]
Mecibah, Ali [1 ]
Merzougui, Zohra [1 ]
Zerguine, Halima [2 ]
Akakba, Zineb [3 ]
Slimani, Samy [4 ]
机构
[1] EPH Houas Salah ORL Clin, Dept Otorhinolaryngol Head & Neck Surg, Benboulaid Batna, Algeria
[2] CHU Benflis Touhami, Dept Pediat, Allees Mohamed Boudiaf, Batna, Algeria
[3] CHU Mustapha Pacha, Dept Cardiol, Algiers, Algeria
[4] Rheumatol Clin, Batna, Algeria
来源
MEDITERRANEAN JOURNAL OF RHEUMATOLOGY | 2023年 / 34卷 / 02期
关键词
Nakajo-Nishimura syndrome; hereditary; Africa; Algeria; chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature; AUTOINFLAMMATORY DISORDER; LIPODYSTROPHY; MUTATION;
D O I
10.31138/mjr.34.2.262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nakajo-Nishimura syndrome is a hereditary autoinflammatory disorder caused by an autosomal recessive homozygous mutation of the PSMB8 gene, which encodes the immunoproteasome subunit beta 5i. The clinical manifestations of NNS are mainly pernio-like skin rashes, nodular erythema, lipodystrophy, clubbed fingers, remittent fever, hepatosplenomegaly, and basal ganglia calcifications. Here we are reporting a case of NNS in an 11-year-old girl, who lives in eastern Algeria, born from a first-degree consanguineous marriage, she presented with erythematous patches on her face and her back, nodular erythema on her neck, swollen and painful fingers with acrocyanosis and recurrent fever that mainly occurred in cold weather. The patient received long-term treatment with low-dose glucocorticoids, along with immunomodulatory drugs (hydroxychloroquine with methotrexate), partial improvement clinically and biologically was observed. Colchicine was added to her treatment, with increased prednisone doses when she recently developed an AA amyloidosis. Our patient was diagnosed clinically with a probable NNS because she exhibited six of the eight characteristics. To the best of our knowledge, this is the first case of NNS in Africa.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Nakajo-Nishimura syndrome, an autoinflammatory disorder with partial lipodystrophy, is caused by a mutation of the PSMB8 gene encoding an immunoproteasome subunit
    Kanazawa, Nobuo
    Kunimoto, Kayo
    Arima, Kazuhiko
    Ida, Hiroaki
    Yoshiura, Kohichiro
    Furukawa, Fukumi
    JOURNAL OF DERMATOLOGY, 2012, 39 : 195 - 195
  • [32] Proteasome inhibitor-associated histiocytoid Sweet's syndrome: Clinical and histological similarities to Nakajo-Nishimura syndrome suggest a potential mechanism
    Cho, Ryang
    Nakajima, Saeko
    Kaku, Yo
    Tezuka, Junko
    Fujimoto, Masakazu
    Kambe, Naotomo
    Kabashima, Kenji
    JOURNAL OF DERMATOLOGY, 2024, 51 (10): : 1355 - 1359
  • [33] Familial Japanese fever (Nakajo-Nishimura syndrome): a novel hereditary periodic fever with partial lipodystrophy and a search for LPIN gene mutations
    Kanazawa, N.
    Mikita, N.
    Furukawa, F.
    Nishimura, H.
    Kawano, S.
    Matsunaka, M.
    Koike, M.
    Sugino, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 174 - 174
  • [34] Comparative study of the skin lesions of Nakajo-Nishimura syndrome and PSMB9-related autoinflammatory syndrome with cutaneous adverse reactions by a proteasome inhibitor
    Kunimoto, K.
    Inaba, Y.
    Kinjo, N.
    Kinoshita, A.
    Yoshiura, K.
    Jinnin, M.
    Kanazawa, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S168 - S168
  • [35] Generation and characterization of the Psmb8 G201V mutation knock-in mice as a model for Nakajo-Nishimura syndrome
    Hara, T.
    Kato, T.
    Hamazaki, J.
    Kinoshita, A.
    Inaba, Y.
    Sasaki, I.
    Yoshiura, K.
    Jinnin, M.
    Kaisho, T.
    Kanazawa, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S14 - S14
  • [36] Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome
    Arima, Kazuhiko
    Kinoshita, Akira
    Mishima, Hiroyuki
    Kanazawa, Nobuo
    Kaneko, Takeumi
    Mizushima, Tsunehiro
    Ichinose, Kunihiro
    Nakamura, Hideki
    Tsujino, Akira
    Kawakami, Atsushi
    Matsunaka, Masahiro
    Kasagi, Shimpei
    Kawano, Seiji
    Kumagai, Shunichi
    Ohmura, Koichiro
    Mimori, Tsuneyo
    Hirano, Makito
    Ueno, Satoshi
    Tanaka, Keiko
    Tanaka, Masami
    Toyoshima, Itaru
    Sugino, Hirotoshi
    Yamakawa, Akio
    Tanaka, Keiji
    Niikawa, Norio
    Furukawa, Fukumi
    Murata, Shigeo
    Eguchi, Katsumi
    Ida, Hiroaki
    Yoshiura, Koh-ichiro
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (36) : 14914 - 14919
  • [37] Pluripotent Stem Cell-Based Screening Identifies CUDC-907 as an Effective Compound for Restoring the In Vitro Phenotype of Nakajo-Nishimura Syndrome (vol 10, pg 455, 2021)
    Kase, Naoya
    Terashima, Madoka
    Ohta, Akira
    Niwa, Akira
    Honda-Ozaki, Fumiko
    Kawasaki, Yuri
    Nakahata, Tatsutoshi
    Kanazawa, Nobuo
    Saito, Megumu K.
    STEM CELLS TRANSLATIONAL MEDICINE, 2023, 12 (02) : 123 - 123
  • [38] First person - Momoe Nakajo
    Nakajo, Momoe
    JOURNAL OF CELL SCIENCE, 2022, 135 (08)
  • [39] First person - Yukako Nishimura
    Nishimura, Yukako
    JOURNAL OF CELL SCIENCE, 2021, 134 (08)
  • [40] RUBINSTEIN-TAYBI SYNDROME - FIRST CASE IN AN AFRICAN CHILD AND FIRST CASE RECOGNIZED AT BIRTH
    SINNETTE, C
    ODEKU, EL
    CLINICAL PEDIATRICS, 1968, 7 (08) : 488 - &